NASDAQ : MDWD
MediWound Ltd. — Financial statements
Healthcare · Biotechnology · Israel
Last price 13.3 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.71M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
MediWound Ltd. (MDWD) reported revenue of 11.86M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 11.86M | 16.96M | 20.22M | 18.69M | 26.50M | 23.76M |
| Cost of Revenue | 10.03M | 13.71M | 17.59M | 15.11M | 13.33M | 14.99M |
| Gross Profit | 1.83M | 3.25M | 2.63M | 3.58M | 13.16M | 8.77M |
| Selling, General & Admin | 15.02M | 14.21M | 13.14M | 11.61M | 10.64M | 9.74M |
| Research & Development | 19.03M | 14.32M | 8.88M | 7.47M | 10.18M | 10.26M |
| Other Operating Expenses | -456.00K | -13.00K | 18.00K | |||
| Operating Expenses | 33.60M | 28.52M | 22.03M | 19.08M | 20.83M | 19.99M |
| Operating Income | -31.76M | -25.27M | -19.40M | -15.50M | -7.66M | -11.22M |
| Interest Expense | -625.00K | -526.00K | -274.00K | -102.00K | -120.00K | |
| Interest & Investment Income | 11.40M | 1.86M | 2.05M | 2.34M | 270.00K | 11.00K |
| Currency Exchange Gain (Loss) | -1.42M | -1.42M | -24.00K | -654.00K | 59.00K | -511.00K |
| Other Non Operating Income (Expenses) | 1.74M | 1.74M | -12.26M | 7.35M | -11.40M | -190.00K |
| EBT Excluding Unusual Items | -20.04M | -23.71M | -30.16M | -6.74M | -18.84M | -12.03M |
| Other Unusual Items | 211.00K | -684.00K | -1.49M | |||
| Pretax Income | -20.04M | -23.71M | -30.16M | -6.53M | -19.52M | -13.52M |
| Income Tax Expense | 142.00K | 169.00K | 61.00K | 185.00K | 78.00K | 27.00K |
| Earnings From Continuing Operations | -20.18M | -23.88M | -30.22M | -6.72M | -19.60M | -13.55M |
| Net Income | -20.18M | -23.88M | -30.22M | -6.72M | -19.60M | -13.55M |
| Net Income to Common | -20.18M | -23.88M | -30.22M | -6.72M | -19.60M | -13.55M |
| Shares Outstanding (Basic) | 12.40M | 11.38M | 9.96M | 9.01M | 4.99M | 3.89M |
| Shares Outstanding (Diluted) | 12.40M | 11.38M | 9.96M | 9.01M | 4.99M | 3.89M |
| EPS (Basic) | -1.63 | -2.10 | -3.03 | -0.75 | -3.93 | -3.48 |
| EPS (Diluted) | -2.25 | -2.10 | -3.03 | -0.75 | -3.93 | -3.48 |
| Free Cash Flow | -28.53M | -21.63M | -19.90M | -16.93M | -12.44M | -9.40M |
| Free Cash Flow Per Share | -2.30 | -1.90 | -2.00 | -1.88 | -2.49 | -2.42 |
| Gross Margin | 15.46% | 19.19% | 13.03% | 19.15% | 49.69% | 36.91% |
| Operating Margin | -267.75% | -148.98% | -95.94% | -82.95% | -28.91% | -47.22% |
| Profit Margin | -170.10% | -140.80% | -149.46% | -35.94% | -73.97% | -57.03% |
| Free Cash Flow Margin | -240.47% | -127.52% | -98.39% | -90.60% | -46.95% | -39.58% |
| EBITDA | -30.75M | -24.28M | -18.64M | -14.20M | -6.39M | -9.98M |
| EBITDA Margin | -259.20% | -143.17% | -92.20% | -75.98% | -24.11% | -42.01% |
| D&A For EBITDA | 1.01M | 986.00K | 755.00K | 1.30M | 1.27M | 1.24M |
| EBIT | -31.76M | -25.27M | -19.40M | -15.50M | -7.66M | -11.22M |
| EBIT Margin | -267.75% | -148.98% | -95.94% | -82.95% | -28.91% | -47.22% |
| Revenue as Reported | 11.86M | 16.96M | 20.22M | 18.69M | 26.50M | 23.76M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.34M | 4.80M | 9.15M | 11.87M | 33.90M | 11.05M |
| Short-Term Investments | 31.00M | 48.34M | 34.01M | 29.68M | ||
| Cash & Short-Term Investments | 35.34M | 53.14M | 43.16M | 41.54M | 33.90M | 11.05M |
| Accounts Receivable | 1.69M | 1.62M | 4.80M | 3.70M | 9.33M | 2.13M |
| Other Receivables | 1.80M | 751.00K | 1.05M | 719.00K | 363.00K | 141.00K |
| Receivables | 3.49M | 2.37M | 5.85M | 4.42M | 9.70M | 2.27M |
| Inventory | 4.12M | 4.09M | 2.69M | 2.85M | 1.96M | 1.20M |
| Prepaid Expenses | 359.00K | 458.00K | 722.00K | 287.00K | 439.00K | |
| Other Current Assets | 167.00K | |||||
| Total Current Assets | 42.95M | 59.96M | 52.16M | 49.70M | 45.84M | 14.95M |
| Property, Plant & Equipment | 28.39M | 25.79M | 20.80M | 15.93M | 3.58M | 4.03M |
| Other Intangible Assets | 33.00K | 99.00K | 165.00K | 231.00K | 297.00K | |
| Other Long-Term Assets | 537.00K | 467.00K | 439.00K | 673.00K | 364.00K | 469.00K |
| Total Assets | 71.88M | 86.25M | 73.50M | 66.46M | 50.02M | 19.74M |
| Accounts Payable | 7.63M | 3.61M | 4.10M | 4.22M | 5.66M | 4.69M |
| Accrued Expenses | 7.17M | 4.06M | 4.75M | 3.19M | 2.30M | |
| Current Portion of Leases | 623.00K | 418.00K | 361.00K | 532.00K | 599.00K | |
| Current Unearned Revenue | 1.43M | 651.00K | 150.00K | 184.00K | 763.00K | |
| Other Current Liabilities | 10.92M | 12.88M | 17.32M | 8.64M | 2.49M | 2.37M |
| Total Current Liabilities | 18.54M | 25.71M | 26.54M | 18.12M | 12.06M | 10.72M |
| Long-Term Leases | 8.61M | 8.15M | 6.51M | 6.35M | 846.00K | 1.39M |
| Long-Term Unearned Revenue | 8.78M | 8.29M | 8.88M | 7.68M | 7.45M | 8.00M |
| Pension & Post-Retirement Benefits | 303.00K | 472.00K | 404.00K | 456.00K | 360.00K | 288.00K |
| Other Long-Term Liabilities | 2.26M | 18.39M | 3.92M | |||
| Total Liabilities | 36.23M | 42.62M | 42.34M | 34.86M | 39.10M | 24.33M |
| Common Stock | 260.00K | 258.00K | 215.00K | 184.00K | 143.00K | 75.00K |
| Additional Paid-In Capital | 274.67M | 272.33M | 236.00M | 206.25M | 178.88M | 143.87M |
| Retained Earnings | -239.27M | -228.93M | -205.05M | -174.82M | -168.11M | -148.51M |
| Comprehensive Income & Other | -21.00K | -32.00K | -11.00K | -18.00K | -5.00K | -19.00K |
| Shareholders' Equity | 35.64M | 43.63M | 31.15M | 31.59M | 10.91M | -4.58M |
| Total Liabilities & Equity | 71.88M | 86.25M | 73.50M | 66.46M | 50.02M | 19.74M |
| Total Debt | 8.61M | 8.78M | 6.93M | 6.71M | 1.38M | 1.99M |
| Net Cash (Debt) | 26.74M | 44.37M | 36.23M | 34.83M | 32.52M | 9.06M |
| Net Cash Per Share | 2.16 | 3.90 | 3.64 | 3.86 | 6.52 | 2.33 |
| Filing Date Shares Outstanding | 12.91M | 12.85M | 10.81M | 9.26M | 9.20M | 4.64M |
| Total Common Shares Outstanding | 12.91M | 12.84M | 10.79M | 9.22M | 7.24M | 3.90M |
| Working Capital | 24.41M | 34.26M | 25.62M | 31.57M | 33.78M | 4.23M |
| Book Value Per Share | 2.76 | 3.40 | 2.89 | 3.43 | 1.51 | -1.18 |
| Tangible Book Value | 35.64M | 43.60M | 31.05M | 31.43M | 10.68M | -4.88M |
| Tangible Book Value Per Share | 2.76 | 3.40 | 2.88 | 3.41 | 1.48 | -1.25 |
| Machinery | 22.54M | 17.63M | 12.99M | 5.55M | 5.20M | |
| Leasehold Improvements | 3.97M | 3.45M | 3.38M | 3.28M | 3.14M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -20.18M | -23.88M | -30.22M | -6.72M | -19.60M | -13.55M |
| Depreciation & Amortization | 1.89M | 1.86M | 1.48M | 1.30M | 1.27M | 1.24M |
| Stock-Based Compensation | 2.80M | 3.11M | 3.14M | 1.94M | 1.95M | 1.67M |
| Other Operating Activities | -12.27M | -1.98M | 10.71M | -9.33M | 11.74M | 1.56M |
| Change in Accounts Receivable | 3.35M | 3.21M | -1.14M | 5.66M | -7.58M | 929.00K |
| Change in Inventory | -243.00K | -1.36M | 187.00K | -906.00K | -721.00K | 257.00K |
| Change in Accounts Payable | 1.51M | 2.35M | 406.00K | -594.00K | 414.00K | 1.72M |
| Change in Unearned Revenue | 724.00K | 1.18M | ||||
| Change in Other Net Operating Assets | 290.00K | 569.00K | 637.00K | -1.82M | 645.00K | -2.75M |
| Operating Cash Flow | -22.14M | -16.12M | -13.62M | -10.46M | -11.88M | -8.92M |
| Capital Expenditures | -6.39M | -5.50M | -6.27M | -6.46M | -555.00K | -489.00K |
| Investment in Securities | 579.00K | -14.04M | -4.38M | -29.80M | 4.00M | |
| Other Investing Activities | 1.67M | 1.59M | 2.25M | 1.95M | 74.00K | 35.00K |
| Investing Cash Flow | -4.15M | -17.95M | -8.40M | -34.32M | -481.00K | 3.55M |
| Long-Term Debt Repaid | -1.21M | -928.00K | -778.00K | -701.00K | -693.00K | |
| Lease Payments | -1.38M | -1.21M | -928.00K | -778.00K | -701.00K | -693.00K |
| Net Debt Issued (Repaid) | -1.38M | -1.21M | -928.00K | -778.00K | -701.00K | -693.00K |
| Issuance of Common Stock | 30.98M | 31.05M | 23.38M | 24.91M | 38.39M | 3.00K |
| Other Financing Activities | -184.00K | -214.00K | -3.05M | -1.21M | -1.93M | -360.00K |
| Financing Cash Flow | 29.41M | 29.62M | 19.39M | 22.92M | 35.76M | -1.05M |
| Foreign Exchange Rate Adjustments | 154.00K | 95.00K | -84.00K | -160.00K | -549.00K | 88.00K |
| Net Cash Flow | 3.29M | -4.36M | -2.71M | -22.03M | 22.85M | -6.33M |
| Free Cash Flow | -28.53M | -21.63M | -19.90M | -16.93M | -12.44M | -9.40M |
| Free Cash Flow Margin | -240.47% | -127.52% | -98.39% | -90.60% | -46.95% | -39.58% |
| Free Cash Flow Per Share | -2.30 | -1.90 | -2.00 | -1.88 | -2.49 | -2.42 |
| Levered Free Cash Flow | -29.05M | -15.58M | -6.59M | -3.05M | -8.82M | -1.36M |
| Unlevered Free Cash Flow | -29.05M | -15.19M | -6.27M | -2.88M | -8.76M | -1.28M |
| Free Cash Flow After Leases | -29.90M | -22.84M | -20.82M | -17.71M | -13.14M | -10.10M |
| Change in Working Capital | 5.62M | 4.77M | 1.27M | 2.34M | -7.24M | 162.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 169.94M | 236.68M | 192.06M | 93.76M | 78.50M | 64.30M |
| Enterprise Value | 143.20M | 185.86M | 152.96M | 54.17M | 62.03M | 52.10M |
| Last Close Price | 13.30 | 18.46 | 17.80 | 10.17 | 13.49 | 16.52 |
| PS Ratio | 14.75 | 13.96 | 9.50 | 5.02 | 2.96 | 2.71 |
| PB Ratio | 4.82 | 5.42 | 6.17 | 2.97 | 7.19 | -14.03 |
| P/TBV Ratio | 4.91 | 5.43 | 6.18 | 2.98 | 7.35 | |
| EV/Sales Ratio | 12.49 | 10.96 | 7.56 | 2.90 | 2.34 | 2.19 |
| Debt / Equity Ratio | 0.24 | 0.20 | 0.22 | 0.21 | 0.13 | -0.43 |
| Net Debt / Equity Ratio | -0.75 | -1.02 | -1.16 | -1.10 | -2.98 | 1.98 |
| Net Debt / EBITDA Ratio | 0.87 | 1.83 | 1.94 | 2.45 | 5.09 | 0.91 |
| Net Debt / FCF Ratio | 0.94 | 2.05 | 1.82 | 2.06 | 2.61 | 0.96 |
| Asset Turnover | 0.17 | 0.21 | 0.29 | 0.32 | 0.76 | 0.94 |
| Inventory Turnover | 2.52 | 4.04 | 6.35 | 6.28 | 8.43 | 11.62 |
| Quick Ratio | 2.09 | 2.16 | 1.85 | 2.54 | 3.62 | 1.24 |
| Current Ratio | 2.32 | 2.33 | 1.97 | 2.74 | 3.80 | 1.40 |
| Return on Equity (ROE) | -72.37% | -63.86% | -96.33% | -31.60% | -619.05% | -1,007.51% |
| Return on Assets (ROA) | -28.59% | -19.77% | -17.33% | -16.63% | -13.73% | -27.60% |
| Return on Capital Employed (ROCE) | -59.60% | -41.70% | -41.30% | -32.10% | -20.20% | -124.40% |
| Earnings Yield | -17.07% | -10.09% | -15.74% | -7.16% | -24.97% | -21.07% |
| FCF Yield | -16.31% | -9.14% | -10.36% | -18.06% | -15.85% | -14.63% |
| Buyback Yield / Dilution | -15.45% | -14.23% | -10.50% | -80.73% | -28.13% | -0.24% |